All research
2026-04-03 PubMed

Growth hormone-releasing hormone antagonist inhibits the invasiveness of human endometrial cancer cells by down-regulating twist and N-cadherin expression.


Summary withdrawn

TitrateLab removes an AI-written study summary when it states findings we cannot trace to the study's own record, or when the study falls outside the compounds we track. Read the original record through the link above.


ghrh-antagonist endometrial-cancer cancer cell-motility in-vitro twist
Source: pubmed:28032599 · Ingested Apr 3, 2026